MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » St. Jude Medical rebounds after “Greek tragedy” | Wall Street Beat

St. Jude Medical rebounds after “Greek tragedy” | Wall Street Beat

By

MassDevice.com Wall Street Beat

Shares of St. Jude Medical (NYSE:STJ) clawed back some of the value lost yesterday in what 1 waggish analyst termed a “Greek tragedy.”

STJ shares closed down 3.3% yesterday at $39.96 when the company revealed a $56 million writedown after a Greek distributor failed to pay up for an estimated 2 years worth of sales.

Calling it a "Greek tragedy," Citigroup analyst Matthew Dodds wrote a research note to investors that St. Jude waited longer than other companies to write down its Greek receivables.

"[St. Jude] has not disclosed how long it has been since this distributor has paid them, but our math suggests $56 million is at least 2 years’ worth of sales in Greece based on competitor sales basis (pre-crisis)," Dodds wrote.

The Greek government, the International Monetary Fund and the European Union inked a deal in February to resolve that country’s massive debt crisis.

"This agreement, among other macroeconomic and factors specific to the distributor, negatively impacted the solvency and liquidity of the company’s Greek distributor, raising significant doubt regarding the collectability of our outstanding accounts receivable balance of approximately $56 million," St. Jude said in the SEC filing. "We have also experienced delays in the collectability of receivables in certain European member states, particularly in Southern Europe. Although we still expect to fully collect these receivables, there can be no assurances that additional negative economic disruptions and slowdowns in Europe may result in us not fully collecting these receivables, adversely affecting our cash flows, financial position and results of operations. Additional prolongation of the economic disruptions in Europe may negatively impact reimbursement rates and procedural volumes and adversely affect our business and results of operations."

STJ shares were trading at $40.91 as of about 11:50 today, up 2.4% on the day.

 Nuance to pay $300M to Transcend

Nuance Communications agreed to pay $300 million to acquire medical transcription and speech editing services provider Transcend Services. Read more

 Report: Syneron in talks to buy TransPharma

Syneron Medical (NSDQ:ELOS) is in talks to purchase transdermal drug delivery firm TransPharma Medical for $15 million, according to an Israeli news outlet. Read more

 ACT’s 2011 cash burn ramps up on clinical trials

Advanced Cell Technology (OTC:ACT) said its cash burn went up 55% last year, as it ramped up the first -ever clinical trial involving human embryonic stem cells. Read more

 CareFusion wins $75M DoD contract

CareFusion (NYSE:CFN) won a $75 million contract from the U.S. Defense Dept. for "medical equipment, maintenance and/or spare parts/repair parts of medical equipment. Read more

 Amgen closes Micromet tender offer

Amgen (NSDQ:AMGN) said it now owns more than 88% of Micromet (NSDQ:MITI) and plans to buy the rest by the end of the day, when MITI shares will cease trading publicly and the $11-per-share, $1.16 billion offer closes. Read more

 Allezoe deals Organ Transport Systems back to Healthcare of Today
Allezoe Medical Holdings (OTC:ALZM) agreed to reverse its takeover of Organ Transport Systems from Healthcare of Today Inc. after it realized it will take about $10 million to get the technology ready for market. Read more

 Hill-Rom raises Q2 dividend
Hill-Rom Holdings (NYSE:HRC) raised its 2nd-quarter dividend by 11 percent to 12.5 cents per share, payable March 30. Read more

 Baxter issues Q4 dividend
Baxter International (NYSE:BAX) declared a quarterly dividend of 33.5 cents per share, payable April 2. Read more

 Nordion issues Q4 dividend

Nordion (NYSE:NDZ) declared a quarterly dividend of 10 cents per share, payable April 5. Read more

 Funding Roundup

 Analysts’ ups and downs

  • Baxter (NYSE:BAX): RBC Capital maintains "outperform" rating.
  • Mako Surgical (NSDQ:MAKO): Leerink Swann maintains "market perform" rating, raises price target from $35 to $39.
  • Zeltiq (NSDQ:ZLTQ): Goldman Sachs downgrades from "buy" to "neutral," lowers price target from $19 to $8.50.

In case you missed it

RSS From Medical Design & Outsourcing

  • These medtech stocks performed the best in 2020
    While 2020 did not go as planned for anyone, with the twists and turns came opportunities for medtech companies to power forward. Innovations came both as a result of the COVID-19 pandemic and perhaps in spite of the challenges brought on by the virus, highlighted by the increased efforts to produce vaccines and testing while… […]
  • Covestro tests plastics against high-strength hospital disinfectants
    Covestro announced that it recently teamed with disinfectant manufacturer Metrex to test six different Covestro polycarbonate materials against three of Metrex’s products, which are widely used throughout the healthcare industry. As is customary for rapidly assessing the compatibility of plastics to disinfectants, test specimens were pre-strained and underwent several wipe-and-dry cycles with Metrex disinfectants to… […]
  • Integer expands N.Y. battery plant
    Integer announced today that it recently broke ground on an expansion of its Alden, N.Y., facility to accommodate new equipment that will substantially increase the plant’s production capacity for rechargeable Xcellion lithium-ion batteries. The project kicked off in mid-December 2020 and will add both production equipment and a build-out of Integer’s existing facility. The company… […]
  • Diversified Plastics adds high-efficiency vertical presses
    Diversified Plastics (DPI) announced that it recently installed six all-electric vertical injection molding presses. These presses will join DPI’s existing assemblage of vertical presses and provide increased production capacity to meet growing demand from medical device and other original equipment manufacturers (OEMs). DPI uses vertical presses for over-molding and insert-molding, capabilities often required for medical… […]
  • Traco Power expands power supply line for portable medical equipment
    Traco Power announced that it has expanded its TPP 450 high-density 3×5 power supply series. The series now offers Protection Class II models (TPP 450BA-M Open-Frame Models and TPP 450B-M Enclosed with Fan Models), designed for non-stationary requirements where connection to ground is not possible. Key approvals on the original series remain on the expanded… […]
  • Reflow Medical launches low-profile reinforced support catheters
    Reflow Medical today announced it has launched its Reflow Spex Low Profile reinforced support catheters. The Spex LP catheters are designed to provide the lowest profile tip to access and cross the tightest and most complex lesions with a supportive system. They come in 0.014 in. and 0.018 in. sizes and can be combined with… […]
  • Former CDER head Woodcock to lead FDA for now
    FDA veteran Dr. Janet Woodcock has been tapped as interim FDA commissioner by the Biden administration, according to published reports. An article by BioCentury also said that former FDA commissioner David Kessler, who had been mentioned as a possible replacement for current commissioner Stephen Hahn, will be a consultant to the agency but will not… […]
  • What’s next for the FDA and for Stephen Hahn?
    Outgoing FDA commissioner Stephen Hahn says he needs some time to reflect on his future after leading the FDA for a little over a year. It’s hard to blame him. Hahn’s brief tenure at FDA has been rocky, to say the least. (News of his temporary replacement broke on Thursday, when the incoming Biden administration… […]
  • Medicare to cover breakthrough devices
    FDA-designated breakthrough devices will have Medicare coverage the same day they are approved, under a final rule issued this week by the Centers for Medicare and Medicaid Services (CMS). The Medicare Coverage of Innovative Technology (MCIT) rule will provide national Medicare coverage as early as the same day as FDA market authorization for breakthrough devices… […]
  • FDA debuts plan for AI-based Software as a Medical Device
    The FDA today released its first plan to regulate artificial intelligence/machine learning (AI/ML)-based Software as a Medical Device (SaMD). The plan is a response to feedback received from the agency’s April 2019 discussion paper, “Proposed Regulatory Framework for Modifications to Artificial Intelligence/Machine Learning-Based Software as a Medical Device.” It outlines five actions that the FDA… […]
  • EU allows remote audits for medical devices during pandemic
    The European Union has announced that it will temporarily allow remote audits of medical devices and in vitro diagnostics under the new regulations (MDR IVDR), set to go into effect on May 2021 and 2022 respectively. In a document published Monday, the European Commission agreed with industry and notified bodies that the ongoing COVID-19 pandemic… […]

Leave a Reply